RNF43 truncations trap CK1 to drive niche-independent self-renewal in cancer

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Science. Official publication website can be found on muni.cz.
Authors

SPIT Maureen FENDERICO Nicola JORDENS Ingrid RADASZKIEWICZ Tomasz Witold LINDEBOOM Rik G. H. BUGTER Jeroen M. CRISTOBAL Alba OOTES Lars VAN OSCH Max JANSSEN Eline BOONEKAMP Kim E. HANÁKOVÁ Kateřina POTĚŠIL David ZDRÁHAL Zbyněk BOJ Sylvia F. MEDEMA Jan Paul BRYJA Vítězslav KOO Bon-Kyoung VERMEULEN Michiel MAURICE Madelon M.

Year of publication 2020
Type Article in Periodical
Magazine / Source EMBO Journal
MU Faculty or unit

Faculty of Science

Citation
Web https://doi.org/10.15252/embj.2019103932
Doi http://dx.doi.org/10.15252/embj.2019103932
Keywords cancer mutations; human colon organoids; PORCNinhibitors; RNF43; Wnt signaling
Description Wnt/beta-catenin signaling is a primary pathway for stem cell maintenance during tissue renewal and a frequent target for mutations in cancer. Impaired Wnt receptor endocytosis due to loss of the ubiquitin ligaseRNF43 gives rise to Wnt-hypersensitive tumors that are susceptible to anti-Wnt-based therapy. Contrary to this paradigm, we identify a class ofRNF43 truncating cancer mutations that induce beta-catenin-mediated transcription, despite exhibiting retained Wnt receptor downregulation. These mutations interfere with a ubiquitin-independent suppressor role of theRNF43 cytosolic tail that involves Casein kinase 1 (CK1) binding and phosphorylation. Mechanistically, truncatedRNF43 variants trapCK1 at the plasma membrane, thereby preventing beta-catenin turnover and propelling ligand-independent target gene transcription. Gene editing of human colon stem cells shows thatRNF43 truncations cooperate with p53 loss to drive a niche-independent program for self-renewal and proliferation. Moreover, theseRNF43 variants confer decreased sensitivity to anti-Wnt-based therapy. Our data demonstrate the relevance of studying patient-derived mutations for understanding disease mechanisms and improved applications of precision medicine.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.